Vaccine trial paused after a participant's illness

AstraZeneca on Tuesday (Sept 8) said it has paused a late-stage trial of one of the leading COVID-19 vaccine candidates after an unexplained illness in a study participant.
WATCH MORE:
SUBSCRIBE:
LIKE:

astrazeneca,trial,covid-19